Mayfield Clinic awarded membership in International Radiosurgery Research Foundation
CINCINNATI - The Mayfield Clinic has been awarded membership into the International Radiosurgery Research Foundation, a consortium of academic and clinical centers of excellence that perform brain stereotactic radiosurgery with the Leksell Gamma Knife®. The consortium’s 30 centers are committed to performing clinical research that will establish best practices and lead to improved outcomes for patients.
Mayfield neurosurgeons treat patients with Gamma Knife technology at The Jewish Hospital -- Mercy Health. Mayfield and The Jewish Hospital Gamma Knife Radiosurgery Center offer patients a professional team that includes neurosurgeons, radiation oncologists, and medical physicists.
Gamma Knife uses precise, high-intensity gamma rays to target lesions in a single session. The method facilitates the treatment of multiple tumors as well as very small tumors deep within the brain. Patients are immobilized with a rigid head frame that is secured with small, titanium pins.
The primary goals of the International Radiosurgery Research Foundation, a non-profit organization, are to facilitate clinical research, to collect long-term outcomes data, and to improve outcomes for patients across a wide spectrum of disease presentation. The foundation’s members include the University of Pittsburgh Medical Center, Cleveland Clinic, New York University Langone Medical Center, Northwestern Memorial, University of California San Francisco, and University of Toronto.
In late 2015 the Mayfield Clinic became one of 30 sites named to a national registry for stereotactic radiosurgery treatment of brain tumors. The registry, which will continue through 2017, is a project of the American Association of Neurological Surgeons (AANS) and the American Society for Radiation Oncology (ASTRO).
The stereotactic radiosurgery registry will define national patterns of care in radiosurgery, with the goal of improving health care outcomes, supporting informed decision-making, and potentially lowering the cost of care for patients. Stereotactic radiosurgery of the brain involves the delivery of high-dose, precisely targeted beams of radiation over one to five sessions.
Mayfield neurosurgeons and their radiation oncology colleagues have been leaders in the technological evolution of stereotactic radiosurgery ever since the treatment of their first patient in 1989. The Mayfield team has treated more than 3,250 patients with stereotactic radiosurgery since then.
***
The Mayfield Clinic, a full-service academic neurosurgery group, is recognized as one of the nation's leading physician organizations for clinical care, education, and research of the spine and brain. With over 20 specialists in neurosurgery, interventional neuroradiology, physical medicine and rehabilitation, and pain management, the Clinic treats 25,000 patients from 35 states and 13 countries in a typical year. Mayfield's physicians have pioneered surgical procedures and instrumentation that have revolutionized the medical art of neurosurgery for spinal diseases and disorders, brain tumors, and neurovascular diseases and disorders. Learn more about Mayfield at mayfieldclinic.com.
